부산대학교 도서관

Andrieu C; Life Sciences Institute, School of Biotechnology, Dublin City University (DCU), Dublin, Ireland.; Stoof J; Life Sciences Institute, School of Biotechnology, Dublin City University (DCU), Dublin, Ireland.; AlSultan D; Life Sciences Institute, School of Biotechnology, Dublin City University (DCU), Dublin, Ireland.; Ivers L; Life Sciences Institute, School of Biotechnology, Dublin City University (DCU), Dublin, Ireland.; Berenguer Pina JJ; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland.; Skrobo D; Department of Histopathology, Galway University Hospital, Galway, Ireland.; Ballot J; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland.; O'Reilly D; Life Sciences Institute, School of Biotechnology, Dublin City University (DCU), Dublin, Ireland.; Collins DM; Life Sciences Institute, School of Biotechnology, Dublin City University (DCU), Dublin, Ireland.; Eustace AJ; Life Sciences Institute, School of Biotechnology, Dublin City University (DCU), Dublin, Ireland.; Quinn C; Department of Pathology, St Vincent's University Hospital, Dublin, Ireland.; Walshe JM; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland.; Gullo G; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland.; Walsh N; Life Sciences Institute, School of Biotechnology, Dublin City University (DCU), Dublin, Ireland. naomi.walsh@dcu.ie.; Crown J; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland. john.crown@ccrt.ie.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE

Eustace, Alex J; Conlon, Neil T; McDermott, Martina S J; Browne, Brigid C; O'Leary, Patrick; Holmes, Frankie A; Espina, Virginia; Liotta, Lance A; O'Shaughnessy, Joyce; Gallagher, Clair; O'Driscoll, Lorraine; Rani, Sweta; Madden, Stephen F; O'Brien, Neil A; Ginther, Charles; Slamon, Dennis; Walsh, Naomi; Gallagher, William M; Zagozdzon, Radoslaw; Watson, William R

BMC Cancer. 10/11/2018, Vol. 18 Issue 1, p1-14. 14p. 2 Charts, 5 Graphs.

Crown J; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland; Life Sciences Institute, Dublin City University, Dublin, Ireland.; Eustace AJ; Life Sciences Institute, Dublin City University, Dublin, Ireland; School of Biotechnology, Dublin City University, Glasnevin, Dublin, Ireland. alex.eustace@dcu.ie.; Collins DM; School of Biotechnology, Dublin City University, Glasnevin, Dublin, Ireland; Cancer Biotherapeutics Research Group, School of Biotechnology, Dublin City University, Dublin, Ireland.; Keane M; Department of Medical Oncology, Galway University Hospital, Ireland.; Coate L; Department of Medical Oncology, University Hospital Limerick, Ireland.; Kennedy J; Department of Medical Oncology, St James's Hospital, Dublin, Ireland.; O'Reilly S; Department of Medical Oncology, Cork University Hospital, Ireland.; Kelly C; Department of Medical Oncology, Mater Hospital, Dublin, Ireland.; O'Connor M; Department of Medical Oncology, Waterford Regional Hospital, Ireland.; Martin M; Department of Medical Oncology, Sligo University Hospital, Ireland.; Murphy C; Department of Medical Oncology, Bons Secours Hospital, Cork, Ireland.; Duffy K; Department of Medical Oncology, Letterkenny University Hospital, Donegal, Ireland.; Walshe J; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland.; Gullo G; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland.; Mahgoub T; Department of Medical Oncology, University Hospital Limerick, Ireland.; Alvarez-Iglesias A; HRB- Clinical Research Facility, Galway, Ireland.; Parker I; Cancer Trials Ireland/ICORG, Dublin, Ireland.; Donachie V; Cancer Trials Ireland/ICORG, Dublin, Ireland.; Teiserskiene A; Cancer Trials Ireland/ICORG, Dublin, Ireland.; Madden SF; Data Science Centre, Royal College of Surgeons in Ireland, Dublin, Ireland.; Moulton B; Clinical Oncology Development Europe, Dublin, Ireland.; O'Donovan N; School of Biotechnology, Dublin City University, Glasnevin, Dublin, Ireland.; Hennessy BT; Department of Medical Oncology/ICORG/Cancer Trials Ireland, Beaumont Hospital, Royal College of Surgeons in Ireland, Dublin, Ireland.

Publisher: Medical Journals Sweden AB Country of Publication: Sweden NLM ID: 8709065 Publication Model: Electronic Cited Medium: Internet ISSN: 1651-226X (Electronic) Linking ISSN: 0284186X NLM ISO Abbreviation: Acta Oncol Subsets: MEDLINE

AlSultan, Dalal; Kavanagh, Emma; O'Grady, Shane; Eustace, Alex J; Castell, Alina; Larsson, Lars-Gunnar; Crown, John; Madden, Stephen F; Duffy, Michael J

Investigational New Drugs; Apr2021, Vol. 39 Issue 2, p587-594, 8p

Rabab KE; Life Sciences Institute, Dublin City University, D09 NR58 Dublin, Ireland.; Buchanan PJ; Life Sciences Institute, Dublin City University, D09 NR58 Dublin, Ireland.; School of Nursing, Psychotherapy and Community Health, Dublin City University, D09 Y8VX Dublin, Ireland.; Colley G; Life Sciences Institute, Dublin City University, D09 NR58 Dublin, Ireland.; White A; Life Sciences Institute, Dublin City University, D09 NR58 Dublin, Ireland.; Murphy A; Life Sciences Institute, Dublin City University, D09 NR58 Dublin, Ireland.; McCormack C; Life Sciences Institute, Dublin City University, D09 NR58 Dublin, Ireland.; Eustace AJ; Life Sciences Institute, Dublin City University, D09 NR58 Dublin, Ireland.; School of Biotechnology, Dublin City University, D09 K20V Dublin, Ireland.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Lynch SM; Personalised Medicine Centre, School of Medicine, Ulster University, C-TRIC Building, Altnagelvin Area Hospital, Glenshane Road, Londonderry BT47 6SB, UK.; Richards CE; School of Dentistry, RCSI University of Medicine and Health Sciences, D02 YN77 Dublin, Ireland.; Ui Mhaonaigh A; Department of Surgery, Trinity Translational Medicine Institute, Trinity St. James's Cancer Institute, St. James's Hospital, Trinity College Dublin, D08 NHY1 Dublin, Ireland.; Lynam-Lennon N; Department of Surgery, Trinity Translational Medicine Institute, Trinity St. James's Cancer Institute, St. James's Hospital, Trinity College Dublin, D08 NHY1 Dublin, Ireland.; Department of Biology, Kathleen Lonsdale Institute for Human Health Research, Maynooth University, W23 NPY6 Maynooth, Ireland.; Eustace AJ; Life Science Institute, School of Biotechnology, Dublin City University, D09 NR58 Dublin, Ireland.; Allott EH; Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Belfast BT9 7AE, UK.; Robson T; School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, D02 YN77 Dublin, Ireland.; Marcone S; UCD School of Biology and Environmental Science, University College Dublin, D04 N2E5 Dublin, Ireland.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Zhou Y; School of Chemical Science, Dublin City University, Glasnevin, Dublin, Ireland. silvia.giordani@dcu.ie.; Life Sciences Institute, Dublin City University, Glasnevin, Dublin, Ireland. alex.eustace@dcu.ie.; Camisasca A; School of Chemical Science, Dublin City University, Glasnevin, Dublin, Ireland. silvia.giordani@dcu.ie.; Dominguez-Gil S; School of Chemical Science, Dublin City University, Glasnevin, Dublin, Ireland. silvia.giordani@dcu.ie.; Bartkowski M; School of Chemical Science, Dublin City University, Glasnevin, Dublin, Ireland. silvia.giordani@dcu.ie.; Rochfort KD; Life Sciences Institute, Dublin City University, Glasnevin, Dublin, Ireland. alex.eustace@dcu.ie.; School of Biotechnology, Dublin City University, Glasnevin, Dublin, Ireland.; Piletti M; Tyndall National Institute, University College Cork, Cork, Ireland.; White A; Life Sciences Institute, Dublin City University, Glasnevin, Dublin, Ireland. alex.eustace@dcu.ie.; School of Biotechnology, Dublin City University, Glasnevin, Dublin, Ireland.; Krizsan D; School of Chemistry, University College Dublin, Belfield, Dublin, Ireland.; O'Connor R; School of Physical Sciences, Dublin City University, Glasnevin, Dublin, Ireland.; Quinn SJ; School of Chemistry, University College Dublin, Belfield, Dublin, Ireland.; Iacopino D; Tyndall National Institute, University College Cork, Cork, Ireland.; Eustace AJ; Life Sciences Institute, Dublin City University, Glasnevin, Dublin, Ireland. alex.eustace@dcu.ie.; School of Biotechnology, Dublin City University, Glasnevin, Dublin, Ireland.; Giordani S; School of Chemical Science, Dublin City University, Glasnevin, Dublin, Ireland. silvia.giordani@dcu.ie.; Life Sciences Institute, Dublin City University, Glasnevin, Dublin, Ireland. alex.eustace@dcu.ie.

Publisher: RSC Pub Country of Publication: England NLM ID: 101525249 Publication Model: Electronic Cited Medium: Internet ISSN: 2040-3372 (Electronic) Linking ISSN: 20403364 NLM ISO Abbreviation: Nanoscale Subsets: MEDLINE

Cosgrove N; Genomic Oncology Research Group, Department of Physiology and Medical Physics, RCSI University of Medicine and Health Sciences, Dublin, Ireland.; Eustace AJ; School of Biotechnology, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.; O'Donovan P; Genomic Oncology Research Group, Department of Physiology and Medical Physics, RCSI University of Medicine and Health Sciences, Dublin, Ireland.; Madden SF; Data Science Centre, RCSI University of Medicine and Health Sciences, Dublin, Ireland.; Moran B; Conway Institute, University College Dublin, Dublin, Ireland.; Crown J; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland.; Moulton B; Clinical Oncology Development Europe, Dublin, Ireland.; Morris PG; Department of Medical Oncology, Beaumont Hospital, Dublin, Ireland.; Grogan L; Department of Medical Oncology, Beaumont Hospital, Dublin, Ireland.; Breathnach O; Department of Medical Oncology, Beaumont Hospital, Dublin, Ireland.; Power C; Department of Surgery, RCSI University of Medicine and Health Sciences, Dublin, Ireland.; Allen M; Department of Surgery, RCSI University of Medicine and Health Sciences, Dublin, Ireland.; Walshe JM; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland.; Hill AD; Department of Surgery, RCSI University of Medicine and Health Sciences, Dublin, Ireland.; Blümel A; School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.; O'Connor D; School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.; Das S; School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.; Milewska M; Medical Oncology Group, Department of Molecular Medicine, Royal College of Surgeons in Ireland, Dublin, 9, Ireland.; Fay J; RCSI Biobank Service, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin, 9, Ireland.; Kay E; Department of Pathology, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin, 9, Ireland.; Toomey S; Medical Oncology Group, Department of Molecular Medicine, Royal College of Surgeons in Ireland, Dublin, 9, Ireland.; Hennessy BT; Department of Medical Oncology, Beaumont Hospital, Dublin, Ireland. bryanhennessy@rcsi.ie.; Medical Oncology Group, Department of Molecular Medicine, Royal College of Surgeons in Ireland, Dublin, 9, Ireland. bryanhennessy@rcsi.ie.; Furney SJ; Genomic Oncology Research Group, Department of Physiology and Medical Physics, RCSI University of Medicine and Health Sciences, Dublin, Ireland. simonfurney@rcsi.ie.

Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Carr A; Department of Medicine, RCSI University of Medicine and Health Sciences, Dublin, Ireland.; Coulter JA; School of Pharmacy, Queen's University Belfast, Belfast, UK.; Workman J; Department of Medicine, RCSI University of Medicine and Health Sciences, Dublin, Ireland.; Fay J; Department of Pathology, RCSI University of Medicine and Health Sciences, Dublin, Ireland.; Farrelly A; Department of Medicine, RCSI University of Medicine and Health Sciences, Dublin, Ireland.; Eustace AJ; Department of Medicine, RCSI University of Medicine and Health Sciences, Dublin, Ireland.; Bennie L; School of Pharmacy, Queen's University Belfast, Belfast, UK.; Grogan L; Department of Medical Oncology, Beaumont Hospital, Dublin, Ireland; Beaumont RCSI Cancer Centre, Dublin, Ireland.; Breathnach O; Department of Medical Oncology, Beaumont Hospital, Dublin, Ireland; Beaumont RCSI Cancer Centre, Dublin, Ireland.; Morris PG; Department of Medical Oncology, Beaumont Hospital, Dublin, Ireland; Beaumont RCSI Cancer Centre, Dublin, Ireland.; McNamara DA; Beaumont RCSI Cancer Centre, Dublin, Ireland; Department of Surgery, RCSI University of Medicine and Health Sciences, Dublin, Ireland.; Cremona M; Department of Medicine, RCSI University of Medicine and Health Sciences, Dublin, Ireland.; O'Neill BDP; Beaumont RCSI Cancer Centre, Dublin, Ireland; St. Luke's Radiation Oncology Network, Dublin, Ireland.; Hennessy BT; Department of Medicine, RCSI University of Medicine and Health Sciences, Dublin, Ireland; Department of Medical Oncology, Beaumont Hospital, Dublin, Ireland; Beaumont RCSI Cancer Centre, Dublin, Ireland.; Toomey S; Department of Medicine, RCSI University of Medicine and Health Sciences, Dublin, Ireland; Beaumont RCSI Cancer Centre, Dublin, Ireland. Electronic address: sineadtoomey@rcsi.ie.

Publisher: Elsevier Country of Publication: England NLM ID: 101694651 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-2942 (Electronic) Linking ISSN: 24682942 NLM ISO Abbreviation: Cancer Treat Res Commun Subsets: MEDLINE

Roche S; National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin, Ireland.; Gaule P; National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin, Ireland.; Winrow D; National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin, Ireland.; Mukherjee N; National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin, Ireland.; O'Neill F; National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin, Ireland.; Conlon NT; National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin, Ireland.; Meiller J; National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin, Ireland.; Collins DM; National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin, Ireland.; Canonici A; National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin, Ireland.; Fawsi MI; National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin, Ireland.; Estepa-Fernández A; National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin, Ireland.; Madden SF; Data Science Centre, Royal College of Surgeons in Ireland, Dublin, Ireland.; Crown J; National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin, Ireland.; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland.; O'Donovan N; National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin, Ireland.; Eustace AJ; National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin, Ireland.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Mukherjee N; National Institute for Cellular Biotechnology, Dublin City University, D09 NR58 Dublin, Ireland.; Department of Molecular and Cellular Biology, ICMR-National Institute for Research on Reproductive and Child Health, JM Street, Mumbai 400012, India.; Browne A; National Institute for Cellular Biotechnology, Dublin City University, D09 NR58 Dublin, Ireland.; Ivers L; National Institute for Cellular Biotechnology, Dublin City University, D09 NR58 Dublin, Ireland.; Santra T; Systems Biology Ireland, School of Medicine, University College Dublin, D04 E1W1 Dublin, Ireland.; Applied Intelligence, Accenture, 1 Grand Canal Square, Grand Canal Dock, D02 P820 Dublin, Ireland.; Cremona M; Medical Oncology Laboratory, Smurfit Building, Beaumont Hospital, Royal College of Surgeons in Ireland, D09 YD60 Dublin, Ireland.; Hennessy BT; Medical Oncology Laboratory, Smurfit Building, Beaumont Hospital, Royal College of Surgeons in Ireland, D09 YD60 Dublin, Ireland.; O'Donovan N; National Institute for Cellular Biotechnology, Dublin City University, D09 NR58 Dublin, Ireland.; Crown J; National Institute for Cellular Biotechnology, Dublin City University, D09 NR58 Dublin, Ireland.; Department of Medical Oncology, Saint Vincent's University Hospital, D04 YN63 Dublin, Ireland.; Kolch W; Systems Biology Ireland, School of Medicine, University College Dublin, D04 E1W1 Dublin, Ireland.; Conway Institute, University College Dublin, D04 E1W1 Dublin, Ireland.; Fey D; Systems Biology Ireland, School of Medicine, University College Dublin, D04 E1W1 Dublin, Ireland.; Eustace AJ; National Institute for Cellular Biotechnology, Dublin City University, D09 NR58 Dublin, Ireland.; School of Biotechnology, Dublin City University, D09 NR58 Dublin, Ireland.

Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101602269 Publication Model: Electronic Cited Medium: Print ISSN: 2075-4426 (Print) Linking ISSN: 20754426 NLM ISO Abbreviation: J Pers Med Subsets: PubMed not MEDLINE

Lynch SM; Personalised Medicine Centre, School of Medicine, Ulster University, C-TRIC Building, Altnagelvin Area Hospital, Glenshane Road, Londonderry BT47 6SB, UK.; Heeran AB; Department of Surgery, Trinity Translational Medicine Institute, Trinity St. James's Cancer Institute, Trinity College Dublin, D02 PN40 Dublin, Ireland.; Burke C; UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Belfield, D04 C1P1 Dublin, Ireland.; Lynam-Lennon N; Department of Surgery, Trinity Translational Medicine Institute, Trinity St. James's Cancer Institute, Trinity College Dublin, D02 PN40 Dublin, Ireland.; Eustace AJ; Life Sciences Institute, Dublin City University, D09 NR58 Dublin, Ireland.; Dean K; School of Biochemistry and Cell Biology, Western Gateway Building, University College Cork, T12 XF62 Cork, Ireland.; Robson T; School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, D02 YN77 Dublin, Ireland.; Rahman A; UCD School of Medicine, UCD Conway Institute, University College Dublin, Belfield, D04 C1P1 Dublin, Ireland.; Marcone S; Department of Surgery, Trinity Translational Medicine Institute, Trinity St. James's Cancer Institute, Trinity College Dublin, D02 PN40 Dublin, Ireland.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Gaynor N; Cancer Biotherapeutics Research Group, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.; Blanco A; Flow Cytometry Core Technology, UCD Conway Institute, University College Dublin, Dublin, Ireland.; Madden SF; Data Science Centre, School of Population Heath Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.; Moran B; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.; Fletcher JM; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.; School of Medicine, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.; Kaukonen D; Data Science Centre, School of Population Heath Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.; Ramírez JS; Cancer Biotherapeutics Research Group, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.; Eustace AJ; School of Biotechnology, Dublin City University, Dublin, Ireland.; McDermott MSJ; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.; Canonici A; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.; Toomey S; Medical Oncology Group, Department of Molecular Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.; Teiserskiene A; Cancer Trials Ireland, RCSI House, 121 St. Stephen's Green, Dublin, Ireland.; Hennessy BT; Medical Oncology Group, Department of Molecular Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.; Cancer Trials Ireland, RCSI House, 121 St. Stephen's Green, Dublin, Ireland.; O'Donovan N; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.; Crown J; Cancer Biotherapeutics Research Group, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland.; Collins DM; Cancer Biotherapeutics Research Group, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland. denis.collins@dcu.ie.

Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

Breen L; Molecular Therapeutics for Cancer in Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.; Gaule PB; Molecular Therapeutics for Cancer in Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.; Canonici A; Molecular Therapeutics for Cancer in Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.; Walsh N; Molecular Therapeutics for Cancer in Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.; Collins DM; Molecular Therapeutics for Cancer in Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.; Cremona M; Medical Oncology Group, Department of Molecular Medicine, Beaumont Hospital, Royal College of Surgeons in Ireland, Dublin, Ireland.; Hennessy BT; Medical Oncology Group, Department of Molecular Medicine, Beaumont Hospital, Royal College of Surgeons in Ireland, Dublin, Ireland.; Duffy MJ; UCD Clinical Research Centre, St. Vincent's University Hospital, Dublin, Ireland.; UCD School of Medicine, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.; Crown J; Molecular Therapeutics for Cancer in Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland.; Donovan NO; Molecular Therapeutics for Cancer in Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.; Eustace AJ; Molecular Therapeutics for Cancer in Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland. alex.eustace@dcu.ie.

Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE

Canonici A; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.; Browne AL; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.; Ibrahim MFK; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.; Fanning KP; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.; Roche S; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.; Conlon NT; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.; O'Neill F; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.; Meiller J; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.; Cremona M; Medical Oncology Group, Department of Molecular Medicine, Beaumont Hospital, Royal College of Surgeons in Ireland, Dublin, Ireland.; Morgan C; Medical Oncology Group, Department of Molecular Medicine, Beaumont Hospital, Royal College of Surgeons in Ireland, Dublin, Ireland.; Hennessy BT; Medical Oncology Group, Department of Molecular Medicine, Beaumont Hospital, Royal College of Surgeons in Ireland, Dublin, Ireland.; Eustace AJ; National Institute for Cellular Biotechnology, Dublin City University, Whitehall, Glasnevin, Dublin 9, Ireland.; Solca F; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.; O'Donovan N; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.; Crown J; National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.

Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE

Kennedy SP; School of Biological, Health and Sports Sciences, Technological University Dublin, D07 ADY7 Dublin, Ireland.; Treacy O; Discipline of Pharmacology and Therapeutics, College of Medicine, Nursing and Health Sciences, University of Galway, H91 TK33 Galway, Ireland.; Allott EH; Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Belfast BT9 7AE, UK.; Department of Histopathology and Morbid Anatomy, Trinity Translational Medicine Institute, Trinity College Dublin, D08 HD53 Dublin, Ireland.; Eustace AJ; National Institute for Cellular Biotechnology, Dublin City University, D09 NR58 Dublin, Ireland.; Lynam-Lennon N; Department of Surgery, Trinity St James's Cancer Institute, Trinity Translational Medicine Institute, St James's Hospital, Trinity College Dublin, D02 PN40 Dublin, Ireland.; Buckley N; School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK.; Robson T; School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons Ireland, D02 YN77 Dublin, Ireland.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Canonici A; National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland.; Qadir Z; National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland.; Conlon NT; National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland.; Collins DM; National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland.; O'Brien NA; Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, CA, Los Angeles, USA.; Walsh N; National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland.; Eustace AJ; National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland. alex.eustace@dcu.ie.; O'Donovan N; National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland.; Crown J; National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland.; Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland.

Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE

Eustace AJ; DCU Cancer Research, Dublin City University, Dublin D9, Ireland.; National Institute Cellular Biotechnology, Dublin City University, Dublin D9, Ireland.; School of Biotechnology, Dublin City University, Dublin D9, Ireland.; Lee MJ; School of Biotechnology, Dublin City University, Dublin D9, Ireland.; Colley G; National Institute Cellular Biotechnology, Dublin City University, Dublin D9, Ireland.; School of Biotechnology, Dublin City University, Dublin D9, Ireland.; Roban J; School of Biotechnology, Dublin City University, Dublin D9, Ireland.; Downing T; DCU Cancer Research, Dublin City University, Dublin D9, Ireland.; School of Biotechnology, Dublin City University, Dublin D9, Ireland.; Buchanan PJ; DCU Cancer Research, Dublin City University, Dublin D9, Ireland.; National Institute Cellular Biotechnology, Dublin City University, Dublin D9, Ireland.; School of Nursing, Psychotherapy, and Community Health, Dublin City University, Dublin D9, Ireland.

Publisher: OAE Publishing Inc Country of Publication: United States NLM ID: 101738710 Publication Model: eCollection Cited Medium: Internet ISSN: 2578-532X (Electronic) Linking ISSN: 2578532X NLM ISO Abbreviation: Cancer Drug Resist Subsets: PubMed not MEDLINE

Milewska M; Medical Oncology Group, Department of Molecular Medicine, Royal College of Surgeons in Ireland, ERC Smurfit Building, Dublin 9 Ireland.; Cremona M; Medical Oncology Group, Department of Molecular Medicine, Royal College of Surgeons in Ireland, ERC Smurfit Building, Dublin 9 Ireland.; Morgan C; Medical Oncology Group, Department of Molecular Medicine, Royal College of Surgeons in Ireland, ERC Smurfit Building, Dublin 9 Ireland.; O'Shea J; Medical Oncology Group, Department of Molecular Medicine, Royal College of Surgeons in Ireland, ERC Smurfit Building, Dublin 9 Ireland.; Carr A; Medical Oncology Group, Department of Molecular Medicine, Royal College of Surgeons in Ireland, ERC Smurfit Building, Dublin 9 Ireland.; Vellanki SH; Department of Surgery, Royal College of Surgeons in Ireland, ERC Smurfit Building, Dublin 9 Ireland.; Hopkins AM; Department of Surgery, Royal College of Surgeons in Ireland, ERC Smurfit Building, Dublin 9 Ireland.; Toomey S; Medical Oncology Group, Department of Molecular Medicine, Royal College of Surgeons in Ireland, ERC Smurfit Building, Dublin 9 Ireland.; Madden SF; Data Science Centre Royal College of Surgeons in Ireland, Ireland.; Hennessy BT; Medical Oncology Group, Department of Molecular Medicine, Royal College of Surgeons in Ireland, Ireland.; Eustace AJ; Medical Oncology Group, Department of Molecular Medicine, Royal College of Surgeons in Ireland, ERC Smurfit Building, Dublin, 9, Ireland.

Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE

Toomey S; Medical Oncology Group, Dept. of Molecular Medicine (ST, AJE, RK, BTH), Department of Pathology (JF, AO, RC, EK), Molecular and Cellular Therapeutics (DO), and Endocrine Oncology Research Group, Department of Surgery (LY), Royal College of Surgeons in Ireland, Dublin, Ireland; RNA Diagnostics Inc., Toronto, Ontario, Canada (LBP, KPHP); Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada (KPHP); Department of Oncology, Beaumont Hospital, Dublin, Ireland (LG, BTH); Department of Oncology, St. James Hospital, Dublin, Ireland (JK); Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland (NO, JC); School of Biomolecular & Biomedical Science, Conway Institute, University College Dublin, Dublin, Ireland (WMG); Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland (JC); All Ireland Clinical Oncology Research Group (BTH).; Eustace AJ; Medical Oncology Group, Dept. of Molecular Medicine (ST, AJE, RK, BTH), Department of Pathology (JF, AO, RC, EK), Molecular and Cellular Therapeutics (DO), and Endocrine Oncology Research Group, Department of Surgery (LY), Royal College of Surgeons in Ireland, Dublin, Ireland; RNA Diagnostics Inc., Toronto, Ontario, Canada (LBP, KPHP); Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada (KPHP); Department of Oncology, Beaumont Hospital, Dublin, Ireland (LG, BTH); Department of Oncology, St. James Hospital, Dublin, Ireland (JK); Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland (NO, JC); School of Biomolecular & Biomedical Science, Conway Institute, University College Dublin, Dublin, Ireland (WMG); Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland (JC); All Ireland Clinical Oncology Research Group (BTH). alexeustace@rcsi.ie.; Pritzker LB; Medical Oncology Group, Dept. of Molecular Medicine (ST, AJE, RK, BTH), Department of Pathology (JF, AO, RC, EK), Molecular and Cellular Therapeutics (DO), and Endocrine Oncology Research Group, Department of Surgery (LY), Royal College of Surgeons in Ireland, Dublin, Ireland; RNA Diagnostics Inc., Toronto, Ontario, Canada (LBP, KPHP); Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada (KPHP); Department of Oncology, Beaumont Hospital, Dublin, Ireland (LG, BTH); Department of Oncology, St. James Hospital, Dublin, Ireland (JK); Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland (NO, JC); School of Biomolecular & Biomedical Science, Conway Institute, University College Dublin, Dublin, Ireland (WMG); Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland (JC); All Ireland Clinical Oncology Research Group (BTH).; Pritzker KP; Medical Oncology Group, Dept. of Molecular Medicine (ST, AJE, RK, BTH), Department of Pathology (JF, AO, RC, EK), Molecular and Cellular Therapeutics (DO), and Endocrine Oncology Research Group, Department of Surgery (LY), Royal College of Surgeons in Ireland, Dublin, Ireland; RNA Diagnostics Inc., Toronto, Ontario, Canada (LBP, KPHP); Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada (KPHP); Department of Oncology, Beaumont Hospital, Dublin, Ireland (LG, BTH); Department of Oncology, St. James Hospital, Dublin, Ireland (JK); Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland (NO, JC); School of Biomolecular & Biomedical Science, Conway Institute, University College Dublin, Dublin, Ireland (WMG); Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland (JC); All Ireland Clinical Oncology Research Group (BTH).; Fay J; Medical Oncology Group, Dept. of Molecular Medicine (ST, AJE, RK, BTH), Department of Pathology (JF, AO, RC, EK), Molecular and Cellular Therapeutics (DO), and Endocrine Oncology Research Group, Department of Surgery (LY), Royal College of Surgeons in Ireland, Dublin, Ireland; RNA Diagnostics Inc., Toronto, Ontario, Canada (LBP, KPHP); Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada (KPHP); Department of Oncology, Beaumont Hospital, Dublin, Ireland (LG, BTH); Department of Oncology, St. James Hospital, Dublin, Ireland (JK); Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland (NO, JC); School of Biomolecular & Biomedical Science, Conway Institute, University College Dublin, Dublin, Ireland (WMG); Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland (JC); All Ireland Clinical Oncology Research Group (BTH).; O'Grady A; Medical Oncology Group, Dept. of Molecular Medicine (ST, AJE, RK, BTH), Department of Pathology (JF, AO, RC, EK), Molecular and Cellular Therapeutics (DO), and Endocrine Oncology Research Group, Department of Surgery (LY), Royal College of Surgeons in Ireland, Dublin, Ireland; RNA Diagnostics Inc., Toronto, Ontario, Canada (LBP, KPHP); Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada (KPHP); Department of Oncology, Beaumont Hospital, Dublin, Ireland (LG, BTH); Department of Oncology, St. James Hospital, Dublin, Ireland (JK); Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland (NO, JC); School of Biomolecular & Biomedical Science, Conway Institute, University College Dublin, Dublin, Ireland (WMG); Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland (JC); All Ireland Clinical Oncology Research Group (BTH).; Cummins R; Medical Oncology Group, Dept. of Molecular Medicine (ST, AJE, RK, BTH), Department of Pathology (JF, AO, RC, EK), Molecular and Cellular Therapeutics (DO), and Endocrine Oncology Research Group, Department of Surgery (LY), Royal College of Surgeons in Ireland, Dublin, Ireland; RNA Diagnostics Inc., Toronto, Ontario, Canada (LBP, KPHP); Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada (KPHP); Department of Oncology, Beaumont Hospital, Dublin, Ireland (LG, BTH); Department of Oncology, St. James Hospital, Dublin, Ireland (JK); Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland (NO, JC); School of Biomolecular & Biomedical Science, Conway Institute, University College Dublin, Dublin, Ireland (WMG); Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland (JC); All Ireland Clinical Oncology Research Group (BTH).; Grogan L; Medical Oncology Group, Dept. of Molecular Medicine (ST, AJE, RK, BTH), Department of Pathology (JF, AO, RC, EK), Molecular and Cellular Therapeutics (DO), and Endocrine Oncology Research Group, Department of Surgery (LY), Royal College of Surgeons in Ireland, Dublin, Ireland; RNA Diagnostics Inc., Toronto, Ontario, Canada (LBP, KPHP); Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada (KPHP); Department of Oncology, Beaumont Hospital, Dublin, Ireland (LG, BTH); Department of Oncology, St. James Hospital, Dublin, Ireland (JK); Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland (NO, JC); School of Biomolecular & Biomedical Science, Conway Institute, University College Dublin, Dublin, Ireland (WMG); Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland (JC); All Ireland Clinical Oncology Research Group (BTH).; Kennedy J; Medical Oncology Group, Dept. of Molecular Medicine (ST, AJE, RK, BTH), Department of Pathology (JF, AO, RC, EK), Molecular and Cellular Therapeutics (DO), and Endocrine Oncology Research Group, Department of Surgery (LY), Royal College of Surgeons in Ireland, Dublin, Ireland; RNA Diagnostics Inc., Toronto, Ontario, Canada (LBP, KPHP); Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada (KPHP); Department of Oncology, Beaumont Hospital, Dublin, Ireland (LG, BTH); Department of Oncology, St. James Hospital, Dublin, Ireland (JK); Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland (NO, JC); School of Biomolecular & Biomedical Science, Conway Institute, University College Dublin, Dublin, Ireland (WMG); Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland (JC); All Ireland Clinical Oncology Research Group (BTH).; O'Connor D; Medical Oncology Group, Dept. of Molecular Medicine (ST, AJE, RK, BTH), Department of Pathology (JF, AO, RC, EK), Molecular and Cellular Therapeutics (DO), and Endocrine Oncology Research Group, Department of Surgery (LY), Royal College of Surgeons in Ireland, Dublin, Ireland; RNA Diagnostics Inc., Toronto, Ontario, Canada (LBP, KPHP); Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada (KPHP); Department of Oncology, Beaumont Hospital, Dublin, Ireland (LG, BTH); Department of Oncology, St. James Hospital, Dublin, Ireland (JK); Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland (NO, JC); School of Biomolecular & Biomedical Science, Conway Institute, University College Dublin, Dublin, Ireland (WMG); Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland (JC); All Ireland Clinical Oncology Research Group (BTH).; Young L; Medical Oncology Group, Dept. of Molecular Medicine (ST, AJE, RK, BTH), Department of Pathology (JF, AO, RC, EK), Molecular and Cellular Therapeutics (DO), and Endocrine Oncology Research Group, Department of Surgery (LY), Royal College of Surgeons in Ireland, Dublin, Ireland; RNA Diagnostics Inc., Toronto, Ontario, Canada (LBP, KPHP); Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada (KPHP); Department of Oncology, Beaumont Hospital, Dublin, Ireland (LG, BTH); Department of Oncology, St. James Hospital, Dublin, Ireland (JK); Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland (NO, JC); School of Biomolecular & Biomedical Science, Conway Institute, University College Dublin, Dublin, Ireland (WMG); Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland (JC); All Ireland Clinical Oncology Research Group (BTH).; Kay EW; Medical Oncology Group, Dept. of Molecular Medicine (ST, AJE, RK, BTH), Department of Pathology (JF, AO, RC, EK), Molecular and Cellular Therapeutics (DO), and Endocrine Oncology Research Group, Department of Surgery (LY), Royal College of Surgeons in Ireland, Dublin, Ireland; RNA Diagnostics Inc., Toronto, Ontario, Canada (LBP, KPHP); Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada (KPHP); Department of Oncology, Beaumont Hospital, Dublin, Ireland (LG, BTH); Department of Oncology, St. James Hospital, Dublin, Ireland (JK); Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland (NO, JC); School of Biomolecular & Biomedical Science, Conway Institute, University College Dublin, Dublin, Ireland (WMG); Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland (JC); All Ireland Clinical Oncology Research Group (BTH).; O'Donovan N; Medical Oncology Group, Dept. of Molecular Medicine (ST, AJE, RK, BTH), Department of Pathology (JF, AO, RC, EK), Molecular and Cellular Therapeutics (DO), and Endocrine Oncology Research Group, Department of Surgery (LY), Royal College of Surgeons in Ireland, Dublin, Ireland; RNA Diagnostics Inc., Toronto, Ontario, Canada (LBP, KPHP); Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada (KPHP); Department of Oncology, Beaumont Hospital, Dublin, Ireland (LG, BTH); Department of Oncology, St. James Hospital, Dublin, Ireland (JK); Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland (NO, JC); School of Biomolecular & Biomedical Science, Conway Institute, University College Dublin, Dublin, Ireland (WMG); Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland (JC); All Ireland Clinical Oncology Research Group (BTH).; Gallagher WM; Medical Oncology Group, Dept. of Molecular Medicine (ST, AJE, RK, BTH), Department of Pathology (JF, AO, RC, EK), Molecular and Cellular Therapeutics (DO), and Endocrine Oncology Research Group, Department of Surgery (LY), Royal College of Surgeons in Ireland, Dublin, Ireland; RNA Diagnostics Inc., Toronto, Ontario, Canada (LBP, KPHP); Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada (KPHP); Department of Oncology, Beaumont Hospital, Dublin, Ireland (LG, BTH); Department of Oncology, St. James Hospital, Dublin, Ireland (JK); Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland (NO, JC); School of Biomolecular & Biomedical Science, Conway Institute, University College Dublin, Dublin, Ireland (WMG); Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland (JC); All Ireland Clinical Oncology Research Group (BTH).; Kalachand R; Medical Oncology Group, Dept. of Molecular Medicine (ST, AJE, RK, BTH), Department of Pathology (JF, AO, RC, EK), Molecular and Cellular Therapeutics (DO), and Endocrine Oncology Research Group, Department of Surgery (LY), Royal College of Surgeons in Ireland, Dublin, Ireland; RNA Diagnostics Inc., Toronto, Ontario, Canada (LBP, KPHP); Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada (KPHP); Department of Oncology, Beaumont Hospital, Dublin, Ireland (LG, BTH); Department of Oncology, St. James Hospital, Dublin, Ireland (JK); Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland (NO, JC); School of Biomolecular & Biomedical Science, Conway Institute, University College Dublin, Dublin, Ireland (WMG); Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland (JC); All Ireland Clinical Oncology Research Group (BTH).; Crown J; Medical Oncology Group, Dept. of Molecular Medicine (ST, AJE, RK, BTH), Department of Pathology (JF, AO, RC, EK), Molecular and Cellular Therapeutics (DO), and Endocrine Oncology Research Group, Department of Surgery (LY), Royal College of Surgeons in Ireland, Dublin, Ireland; RNA Diagnostics Inc., Toronto, Ontario, Canada (LBP, KPHP); Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada (KPHP); Department of Oncology, Beaumont Hospital, Dublin, Ireland (LG, BTH); Department of Oncology, St. James Hospital, Dublin, Ireland (JK); Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland (NO, JC); School of Biomolecular & Biomedical Science, Conway Institute, University College Dublin, Dublin, Ireland (WMG); Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland (JC); All Ireland Clinical Oncology Research Group (BTH).; Hennessy BT; Medical Oncology Group, Dept. of Molecular Medicine (ST, AJE, RK, BTH), Department of Pathology (JF, AO, RC, EK), Molecular and Cellular Therapeutics (DO), and Endocrine Oncology Research Group, Department of Surgery (LY), Royal College of Surgeons in Ireland, Dublin, Ireland; RNA Diagnostics Inc., Toronto, Ontario, Canada (LBP, KPHP); Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada (KPHP); Department of Oncology, Beaumont Hospital, Dublin, Ireland (LG, BTH); Department of Oncology, St. James Hospital, Dublin, Ireland (JK); Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland (NO, JC); School of Biomolecular & Biomedical Science, Conway Institute, University College Dublin, Dublin, Ireland (WMG); Department of Medical Oncology, St Vincent's University Hospital, Dublin, Ireland (JC); All Ireland Clinical Oncology Research Group (BTH).

Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE